PJ, 5 July 2014, Vol 293, No 7817

TNF-α antagonists not linked with cancer in Danish study

The use of tumour necrosis factor alpha (TNF-α) antagonists to treat inflammatory bowel disease (IBD) is not associated with an increased risk of cancer, analysis of a Danish registry indicates[1] . The analysis, conducted by researchers from Statens Serum Institute and …

Cancer: Body out of sync

The body clock of mammals — or circadian rhythm — is synchronised with the cell-division cycle, but little is known about how the two work together. Now a team of researchers from The Rockefeller University in New York have imaged single proliferating fibroblasts in mice and found …

Pinpointing a weakness in bacteria’s protective barrier

An international team of scientists have identified how gram-negative bacteria build a protective barrier against antibiotics.…

Patients satisfied with pharmacists treating minor ailments

More than 80% of patients with minor ailments said their condition either cleared up or significantly improved after they were prescribed treatment by a community pharmacist.…

Enhancing patient care through research

Bryony Dean Franklin describes what participants can take away from the research stream she is chairing at this year’s Annual Conference…

Promoting drug-free sport as a doping control officer

Pharmacist Carole Hunter, a doping control officer at the Commonwealth Games in Glasgow in July 2014, explains her part in trying to rid sport of performance-enhancing drugs.…

Medicines information services benefit patients

Pharmacy-led medicines information services improve patient care and clinical outcomes, results of a UK-wide study confirm.…

New care pathway for dying patients in England published

A new approach to caring for dying people that will replace the Liverpool Care Pathway in England has been published.…